We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Orbit

News List

Orbit Discovery raises $7.6m to boost peptide drug discovery services pharmatimes
July 22, 2021
Oxford, UK-based Orbit Discoveries has raised $7.6m in funding to boost its peptide drug discovery services and accelerate the growth of its business.
NICE updates guideline on atrial fibrillation pharmatimes
April 28, 2021
The UK’s National Institute for Health and Care Excellence has published an updated clinical guideline on the diagnosis and management of atrial fibrillation (AF) addressing several areas of new evidence.
Mario Polywka Joins Orbit Discovery’s Board of Directors b3cnewswire
September 03, 2019
Orbit Discovery, an Oxford, UK-based biotech company developing an industry-leading peptide discovery platform, are pleased to announce that Dr Mario Polywka has joined their board as a non-executive director.